Indicated for: botulism
Route of administration: injectable
Substance: botulinum antitoxin (therapeutic serum)
ATC: J06AA04 (Antiinfectives for systemic use | Immune sera)
Botulinum antitoxin is a treatment used to neutralize botulinum toxin, produced by the bacterium Clostridium botulinum. It is indicated in cases of botulism, a serious condition that can cause muscle paralysis and respiratory failure.
The antitoxin works by binding to free botulinum toxin in the bloodstream, preventing its effects on the nervous system. It is effective only if administered early after symptom onset, as it cannot reverse already established paralysis but can stop the progression of the disease.
It is available as an injectable solution and is administered intravenously, usually in a hospital setting under strict medical supervision.
Side effects may include fever, skin rashes, pain at the injection site, or, rarely, severe allergic reactions. Prompt administration is crucial, as botulism is a medical emergency requiring immediate intervention.